372
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?

, , &
Pages 1087-1090 | Received 06 Dec 2018, Accepted 20 Mar 2019, Published online: 28 Mar 2019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.